NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>NHMRC</strong> GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA<br />
Chapter 10 – Laser therapy and surgery<br />
■ Chapter 10<br />
Laser therapy and surgery<br />
Recommendation 12<br />
Reduce IOP by using laser techniques and incisional surgery.<br />
Good Practice Points<br />
• Offer laser trabeculoplasty as an alternative, or additive to medications.<br />
• Offer surgical IOP reduction when medications and/or laser trabeculoplasty fail to meet targets or are<br />
unsuitable, and visual disability is threatened. There are inherent risks with invasive procedures, which<br />
must be justified by likely benefits.<br />
• <strong>Glaucoma</strong> drainage devices may control IOP long-term and may be suitable if other drainage surgery<br />
fails, or as first-line surgery in eyes with higher risks of failure (including inflammatory glaucomas and<br />
ICE syndrome).<br />
Recommendation 13<br />
If indicated, perform prophylactic laser peripheral iridotomy in both eyes to<br />
prevent progressive anterior segment damage.<br />
Good Practice Point<br />
• Peripheral iridoplasty might be useful after iridotomy in individual cases. Consider cataract extraction<br />
and ongoing IOP control, including trabeculectomy as required.<br />
Recommendation 14<br />
Ensure patients are aware of risks and symptoms of angle-closure and can<br />
access care urgently as necessary.<br />
Introduction<br />
All clinical guidelines highlight the importance of choosing the most appropriate management<br />
approach on a case-by-case basis. Traditionally, glaucoma treatment has begun with medications,<br />
proceeding to laser therapy and surgery when necessary. This approach was designed to maximise<br />
the benefit of treatment while minimising risk to the patient. When making the choice of a<br />
specific form of treatment or the decision to alter or provide additional treatment, the overriding<br />
consideration must be to minimise the risks and maximise the benefit to the patient. All forms of<br />
treatment for glaucoma have potential side effects or complications, and the possible impact of the<br />
treatment, must be evaluated from a social, psychological, financial, and convenience standpoint.<br />
National Health and Medical Research Council 139